Delivery Order SPE2DB20D1110-SPE2DB24FK19P
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $7,828.66 and a period of performance through August 21, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of its extensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.55 firm fixed price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of February 6, 2023 and was awarded on January 13, 2023. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,893.15, was granted by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, to the government. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves...
- This is a $3,553.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a prescription medication. The order has an ultimate completion date of March 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $3,676.12 firm fixed-price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has a period of performance through December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $8,022.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product, with a performance period through April 11, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $3,893.15 firm fixed-price delivery order is for the provision of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,022.00 firm fixed-price delivery order is for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of May 10, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,049.61 firm-fixed-price contract is for the supply of INGREZZA 60 MG CAPSULE 30S, a medication, with a period of performance through July 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FK19PDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $8,420.10 firm-fixed-price contract is for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of May 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract award appears to be a task order under that larger IDC. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 5/8/24 |